Galapagos announces capital increase
April 21 2017 - 4:01PM
Mechelen,
Belgium; 21 April 2017, 22.01 CET; regulated information -
Galapagos NV (Euronext: GLPG; Nasdaq: GLPG) announces a share
capital increase as a result of a public offering of American
Depositary Shares.
In accordance with Belgian
transparency legislation[1], Galapagos
notes that its total share capital currently amounts to
€274,854,440.18; the total number of securities conferring voting
rights is 50,815,648, which is also the total number of voting
rights (the "denominator"), and all securities conferring voting
rights and all voting rights are of the same category. The total
number of rights (warrants) to subscribe to not yet issued
securities conferring voting rights is 3,369,337, which equals the
total number of voting rights that may result from the exercise of
these warrants. Galapagos does not have any convertible bonds or
shares without voting rights outstanding.
About Galapagos
Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage
biotechnology company specialized in the discovery and development
of small molecule medicines with novel modes of action. Our
pipeline comprises Phase 3, 2, 1, pre-clinical and discovery
studies in cystic fibrosis, inflammation, fibrosis, osteoarthritis
and other indications. We have discovered and developed filgotinib:
in collaboration with Gilead we aim to bring this JAK1-selective
inhibitor for inflammatory indications to patients all over the
world. Galapagos is focused on the development and
commercialization of novel medicines that will improve people's
lives. The Galapagos group, including fee-for-service subsidiary
Fidelta, has approximately 510 employees, operating from its
Mechelen, Belgium headquarters and facilities in The
Netherlands, France, and Croatia.
CONTACT
Investors: |
Media: |
Elizabeth Goodwin |
Evelyn Fox |
VP IR & Corporate
Communications
+1 781 460 1784 |
Director Communications
+31 6 53 591 999
communications@glpg.com |
Paul van der Horst
Director IR & Business
Development
+31 6 53 725 199 |
|
ir@glpg.com |
|
Forward-looking
statements
This release may contain forward-looking
statements. Such forward-looking statements are not guarantees of
future results. These forward-looking statements speak only as of
the date of publication of this document. Galapagos expressly
disclaims any obligation to update any forward-looking statements
in this document, unless specifically required by law or
regulation.
[1] Belgian Act
of 2 May 2007 on the disclosure of major shareholdings in issuers
whose shares are admitted to trading on a regulated market.
GLPG announces capital
increase
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Galapagos NV via Globenewswire
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Sep 2023 to Sep 2024